相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Regulatory T Cells Shape the Differential Impact of Radiation Dose-Fractionation Schedules on Host Innate and Adaptive Antitumor Immune Defenses
Joseph Sia et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2021)
The lncRNAs LINC00261 and LINC00665 are upregulated in long-term prostate cancer adaptation after radiotherapy
Iris Eke et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2021)
53BP1/RIF1 signaling promotes cell survival after multifractionated radiotherapy
Iris Eke et al.
NUCLEIC ACIDS RESEARCH (2020)
CD73 Blockade Promotes Dendritic Cell Infiltration of Irradiated Tumors and Tumor Rejection
Erik Wennerberg et al.
CANCER IMMUNOLOGY RESEARCH (2020)
High dose-rate brachytherapy of localized prostate cancer converts tumors from cold to hot
Simon P. Keam et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
Immune molecular profiling of a multiresistant primary prostate cancer with a neuroendocrine-like phenotype: a case report
Scott G. Williams et al.
BMC UROLOGY (2020)
Immunogenicity of prostate cancer is augmented by BET bromodomain inhibition
Wendy Mao et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Cancer statistics, 2019
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2019)
Exploiting Radiation-Induced Signaling to Increase the Susceptibility of Resistant Cancer Cells to Targeted Drugs: AKT and mTOR Inhibitors as an Example
Iris Eke et al.
MOLECULAR CANCER THERAPEUTICS (2018)
Cancer testis antigens as immunogenic and oncogenic targets in breast cancer
Abeer M. Mahmoud
IMMUNOTHERAPY (2018)
Long-term Tumor Adaptation after Radiotherapy: Therapeutic Implications for Targeting Integrins in Prostate Cancer
Iris Eke et al.
MOLECULAR CANCER RESEARCH (2018)
Immunotherapy in Prostate Cancer: Teaching an Old Dog New Tricks
Michael C. Comiskey et al.
CURRENT ONCOLOGY REPORTS (2018)
Radiotherapy induces responses of lung cancer to CTLA-4 blockade
Silvia C. Formenti et al.
NATURE MEDICINE (2018)
The synergy between ionizing radiation and immunotherapy in the treatment of prostate cancer
Niranjan J. Sathianathen et al.
IMMUNOTHERAPY (2017)
DNA exonuclease Trex1 regulates radiotherapy-induced tumour immunogenicity
Claire Vanpouille-Box et al.
NATURE COMMUNICATIONS (2017)
Comparison of outcomes and toxicities among radiation therapy treatment options for prostate cancer
Nicholas G. Zaorsky et al.
CANCER TREATMENT REVIEWS (2016)
Combination Cancer Therapies with Immune Checkpoint Blockade: Convergence on Interferon Signaling
Andy J. Minn et al.
CELL (2016)
SSX2 regulates focal adhesion but does not drive the epithelial to mesenchymal transition in prostate cancer
Jordan E. Bloom et al.
ONCOTARGET (2016)
Interferon-induced transmembrane protein 1 (IFITM1) overexpression enhances the aggressive phenotype of SUM149 inflammatory breast cancer cells in a signal transducer and activator of transcription 2 (STAT2)-dependent manner
Joshua Ogony et al.
BREAST CANCER RESEARCH (2016)
Optimal Treatment Sequence for Metastatic Castration-resistant Prostate Cancer
David Lorente et al.
EUROPEAN UROLOGY FOCUS (2016)
IFITM1 promotes the metastasis of human colorectal cancer via CAV-1
Fang Yu et al.
CANCER LETTERS (2015)
Inhibiting DNA Methylation Causes an Interferon Response in Cancer via dsRNA Including Endogenous Retroviruses
Katherine B. Chiappinelli et al.
CELL (2015)
Simultaneous β1 integrin-EGFR Targeting and Radiosensitization of Human Head and Neck Cancer
Iris Eke et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Simultaneous β1 integrin-EGFR Targeting and Radiosensitization of Human Head and Neck Cancer
Iris Eke et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Role of Local Radiation Therapy in Cancer Immunotherapy
Sandra Demaria et al.
JAMA ONCOLOGY (2015)
Ectopic expression of cancer/testis antigen SSX2 induces DNA damage and promotes genomic instability
Katrine B. V. Greve et al.
MOLECULAR ONCOLOGY (2015)
Differential Expression of Stress and Immune Response Pathway Transcripts and miRNAs in Normal Human Endothelial Cells Subjected to Fractionated or Single-Dose Radiation
Sanjeewani T. Palayoor et al.
MOLECULAR CANCER RESEARCH (2014)
Cancer cell-autonomous contribution of type I interferon signaling to the efficacy of chemotherapy
Antonella Sistigu et al.
NATURE MEDICINE (2014)
Defining Molecular Signature of Pro-Immunogenic Radiotherapy Targets in Human Prostate Cancer Cells
Molykutty J. Aryankalayil et al.
RADIATION RESEARCH (2014)
EGFR/JIP-4/JNK2 Signaling Attenuates Cetuximab-Mediated Radiosensitization of Squamous Cell Carcinoma Cells
Iris Eke et al.
CANCER RESEARCH (2013)
Effects of Clostridium difficile Toxin A and B on Human T Lymphocyte Migration
Dan Wu et al.
TOXINS (2013)
Overexpression of IFITM1 Has Clinicopathologic Effects on Gastric Cancer and Is Regulated by an Epigenetic Mechanism
Jieun Lee et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
Cancer immune escape: implications for immunotherapy, Granada, Spain, October 3–5, 2011
Natalia Aptsiauri et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2012)
Maximizing Tumor Immunity With Fractionated Radiation
Doerthe Schaue et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2012)
The SSX Family of Cancer-Testis Antigens as Target Proteins for Tumor Therapy
Heath A. Smith et al.
CLINICAL & DEVELOPMENTAL IMMUNOLOGY (2010)
Cancer/testis antigens can be immunological targets in clonogenic CD133+ melanoma cells
Craig Gedye et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2009)
Cancer/testis (CT) antigens: Potential targets for immunotherapy
Otavia L. Caballero et al.
CANCER SCIENCE (2009)
Gene expression profiling of breast, prostate, and glioma cells following single versus fractionated doses of radiation
Mong-Hsun Tsai et al.
CANCER RESEARCH (2007)
Radiation-induced cell signaling: inside-out and outside-in
Kristoffer Valerie et al.
MOLECULAR CANCER THERAPEUTICS (2007)
Curative antitumor immune response is optimal with tumor irradiation followed by genetic induction of major histocompatibility complex class I and class II molecules and suppression of Ii protein
Y Wang et al.
HUMAN GENE THERAPY (2005)
Sublethal irradiation of human tumor cells modulates phenotype resulting in enhanced killing by cytotoxic T lymphocytes
CT Garnett et al.
CANCER RESEARCH (2004)
Molecular characterization of human prostate carcinoma cell lines
A van Bokhoven et al.
PROSTATE (2003)